153 related articles for article (PubMed ID: 10772724)
1. Differential transport of cytosine-containing nucleosides by recombinant human concentrative nucleoside transporter protein hCNT1.
Graham KA; Leithoff J; Coe IR; Mowles D; Mackey JR; Young JD; Cass CE
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):415-34. PubMed ID: 10772724
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters.
Mackey JR; Yao SY; Smith KM; Karpinski E; Baldwin SA; Cass CE; Young JD
J Natl Cancer Inst; 1999 Nov; 91(21):1876-81. PubMed ID: 10547395
[TBL] [Abstract][Full Text] [Related]
3. Electrogenic uptake of nucleosides and nucleoside-derived drugs by the human nucleoside transporter 1 (hCNT1) expressed in Xenopus laevis oocytes.
Lostao MP; Mata JF; Larrayoz IM; Inzillo SM; Casado FJ; Pastor-Anglada M
FEBS Lett; 2000 Sep; 481(2):137-40. PubMed ID: 10996312
[TBL] [Abstract][Full Text] [Related]
4. Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1.
Damaraju VL; Smith KM; Mowles D; Nowak I; Karpinski E; Young JD; Robins MJ; Cass CE
Biochem Pharmacol; 2011 Jan; 81(1):82-90. PubMed ID: 20854794
[TBL] [Abstract][Full Text] [Related]
5. Cytidine is a novel substrate for wild-type concentrative nucleoside transporter 2.
Nagai K; Nagasawa K; Koma M; Hotta A; Fujimoto S
Biochem Biophys Res Commun; 2006 Aug; 347(2):439-43. PubMed ID: 16828706
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cells.
Fang X; Parkinson FE; Mowles DA; Young JD; Cass CE
Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):457-65. PubMed ID: 8713072
[TBL] [Abstract][Full Text] [Related]
7. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines.
Mackey JR; Mani RS; Selner M; Mowles D; Young JD; Belt JA; Crawford CR; Cass CE
Cancer Res; 1998 Oct; 58(19):4349-57. PubMed ID: 9766663
[TBL] [Abstract][Full Text] [Related]
8. Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity.
García-Manteiga J; Molina-Arcas M; Casado FJ; Mazo A; Pastor-Anglada M
Clin Cancer Res; 2003 Oct; 9(13):5000-8. PubMed ID: 14581375
[TBL] [Abstract][Full Text] [Related]
9. Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[Prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug.
Mata JF; García-Manteiga JM; Lostao MP; Fernández-Veledo S; Guillén-Gómez E; Larrayoz IM; Lloberas J; Casado FJ; Pastor-Anglada M
Mol Pharmacol; 2001 Jun; 59(6):1542-8. PubMed ID: 11353816
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.
Gourdeau H; Clarke ML; Ouellet F; Mowles D; Selner M; Richard A; Lee N; Mackey JR; Young JD; Jolivet J; Lafrenière RG; Cass CE
Cancer Res; 2001 Oct; 61(19):7217-24. PubMed ID: 11585758
[TBL] [Abstract][Full Text] [Related]
11. The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.
Clarke ML; Damaraju VL; Zhang J; Mowles D; Tackaberry T; Lang T; Smith KM; Young JD; Tomkinson B; Cass CE
Mol Pharmacol; 2006 Jul; 70(1):303-10. PubMed ID: 16617163
[TBL] [Abstract][Full Text] [Related]
12. Erlotinib, gefitinib, and vandetanib inhibit human nucleoside transporters and protect cancer cells from gemcitabine cytotoxicity.
Damaraju VL; Scriver T; Mowles D; Kuzma M; Ryan AJ; Cass CE; Sawyer MB
Clin Cancer Res; 2014 Jan; 20(1):176-86. PubMed ID: 24170548
[TBL] [Abstract][Full Text] [Related]
13. Seeking the nucleoside transporter.
Wiley JS
Nat Med; 1997 Jan; 3(1):25-6. PubMed ID: 8986733
[No Abstract] [Full Text] [Related]
14. Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approach.
Hung SW; Marrache S; Cummins S; Bhutia YD; Mody H; Hooks SB; Dhar S; Govindarajan R
Cancer Lett; 2015 Apr; 359(2):233-40. PubMed ID: 25600708
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes.
Smith KM; Ng AM; Yao SY; Labedz KA; Knaus EE; Wiebe LI; Cass CE; Baldwin SA; Chen XZ; Karpinski E; Young JD
J Physiol; 2004 Aug; 558(Pt 3):807-23. PubMed ID: 15194733
[TBL] [Abstract][Full Text] [Related]
16. Human concentrative nucleoside transporter 1-mediated uptake of 5-azacytidine enhances DNA demethylation.
Rius M; Stresemann C; Keller D; Brom M; Schirrmacher E; Keppler D; Lyko F
Mol Cancer Ther; 2009 Jan; 8(1):225-31. PubMed ID: 19139132
[TBL] [Abstract][Full Text] [Related]
17. Transport of physiological nucleosides and anti-viral and anti-neoplastic nucleoside drugs by recombinant Escherichia coli nucleoside-H(+) cotransporter (NupC) produced in Xenopus laevis oocytes.
Loewen SK; Yao SY; Slugoski MD; Mohabir NN; Turner RJ; Mackey JR; Weiner JH; Gallagher MP; Henderson PJ; Baldwin SA; Cass CE; Young JD
Mol Membr Biol; 2004; 21(1):1-10. PubMed ID: 14668133
[TBL] [Abstract][Full Text] [Related]
18. Specific mutations in transmembrane helix 8 of human concentrative Na+/nucleoside cotransporter hCNT1 affect permeant selectivity and cation coupling.
Slugoski MD; Loewen SK; Ng AM; Smith KM; Yao SY; Karpinski E; Cass CE; Baldwin SA; Young JD
Biochemistry; 2007 Feb; 46(6):1684-93. PubMed ID: 17279631
[TBL] [Abstract][Full Text] [Related]
19. Identification of amino acid residues responsible for the pyrimidine and purine nucleoside specificities of human concentrative Na(+) nucleoside cotransporters hCNT1 and hCNT2.
Loewen SK; Ng AM; Yao SY; Cass CE; Baldwin SA; Young JD
J Biol Chem; 1999 Aug; 274(35):24475-84. PubMed ID: 10455109
[TBL] [Abstract][Full Text] [Related]
20. Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line.
Lang TT; Young JD; Cass CE
Mol Pharmacol; 2004 Apr; 65(4):925-33. PubMed ID: 15044622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]